Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Seletracetam add-on in refractory partial epilepsy
NCT00152503Phase 2Completed
- Sponsor
- UCB
- Start
- Aug 2005
- Primary completion
- May 2006
- Modality
- Small Molecules
- Countries
- 2
01
Overview
Phase 2, open-label, single-arm trial of seletracetam in focal onset seizure, sponsored by UCB. Primary endpoint: Percent Change From Baseline in Seizure Frequency Per Week for Partial Onset Seizures (Type I). Started Aug 2005; status: completed.
02
Drugs
seletracetam
03
Conditions
focal onset seizure
Beyond the preview
Go deeper on NCT00152503.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00152503.